Cancer Immunotherapy: Building on Initial Successes to Improve Clinical Outcomes
Cambridge Healthtech Institute (CHI) announced the publication of a new book-length report, Cancer Immunotherapy: Building on Initial Successes to Improve Clinical Outcomes, by Allan B. Haberman, Ph.D. Learn More
Gene Therapy: Moving Toward Commercialization
Cambridge Healthtech Institute (CHI) announced the publication of a new book-length report, Gene Therapy: Moving Toward Commercialization, by Allan B. Haberman, Ph.D. Learn More
Cancer Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies
Cambridge Healthtech Institute (CHI) announced the publication of a new book-length report, Cancer Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies, by Allan B. Haberman, Ph.D.
Learn More
Advances in the Discovery of Protein-Protein Interaction Modulators
Informa’s Scrip Insights announced the publication of a new book-length report, Advances in the Discovery of Protein-Protein Interaction Modulators available as FREE DOWNLOAD by Allan B. Haberman, Ph.D. Learn More
Multitargeted Therapies: Promiscuous Drugs and Combination Therapies
Cambridge Healthtech Institute (CHI) announced the publication of a new book-length report, Multitargeted Therapies: Promiscuous Drugs and Combination Therapies, by Allan B. Haberman, Ph.D. Learn More
RNAi Therapeutics: Second Generation Candidates Build Momentum
Cambridge Healthtech Institute (CHI) announced the publication of a new book-length report, RNAi Therapeutics: Second Generation Candidates Build Momentum, by Allan B. Haberman, Ph.D. Learn More
Animal Models for Therapeutic Strategies
Cambridge Healthtech Institute (CHI) announced the publication of a new book-length report, Animal Models for Therapeutic Strategies, by Allan B. Haberman, Ph.D. Learn More
Approaches to Reducing Phase II Attrition
Cambridge Healthtech Institute (CHI) announced the publication of a book-length report, Approaches to Reducing Phase II Attrition, by Allan B. Haberman, Ph.D. Learn More
Obesity Drug Pipeline: Developing Therapies for a Complex Disease
Cambridge Healthtech Institute (CHI) announced the publication of a book-length report, Obesity Drug Pipeline: Developing Therapies for a Complex Disease, by Allan B. Haberman, Ph.D Learn More
Blood-Brain Barrier: Bridging Options for Drug Discovery and Development
Cambridge Healthtech Institute (CHI) announced the publication of a book-length report, Blood-Brain Barrier: Bridging Options for Drug Discovery and Development, by Allan B. Haberman, Ph.D. Learn More
Diabetes and Its Complications: Strategies to Advance Therapy and Optimize R&D
Insight Pharma Reports (formerly Advanced Reports) announced the publication of a book-length report, Diabetes and Its Complications: Strategies to Advance Therapy and Optimize R&D, by Allan B. Haberman, Ph.D. Learn More
Our Published Articles
Follow the links below for your free PDF download of article.
We also produce articles that have appeared in such leading publications as Genetic Engineering & Biotechnology News, Pharma DD and PharmaWeek. Links for FREE DOWNLOAD of some of our published articles below:
“Overcoming Phase II Attrition Problem”
(Published in the August 2009 issue of Genetic Engineering & Biotechnology News.)
“Strategies to Overcome Blood-Brain Barrier”
(Published in the February 1, 2009 issue of Genetic Engineering & Biotechnology News.)
“Addressing Unmet Type 2 Diabetes Needs”
(Published in the January 1, 2008 issue of Genetic Engineering & Biotechnology News.)
“Recent Clinical Developments in Type 2 Diabetes: Preventing Diabetes and Preventing Cardiovascular Events in Diabetics”
(Published in the October 19, 2006 issue of CHI’s Pharma DD.)
“Safety Issues Hamper Dual PPAR Agonists: Is Partial Antagonism the Solution?”
(Published in the September 22, 2006 issue of CHI’s Pharma DD.)
“Breaking the Obesity Barrier: Near-Term Prospects for Breakthrough Treatments”
(Published in the December 22, 2005 issue of CHI’s PharmaWeek.)
“Strategies to Move Beyond Target Validation: Targets and Druggability for Smalland Large Molecule Drugs”
(Published in the December 1, 2005 issue of Genetic Engineering & Biotechnology News.)
“Therapeutic Strategies in Animal Models: the Case of Alzheimer’s Disease.”
(Published in the September 15, 2004 issue of Genetic Engineering & Biotechnology News.)